Abstract:The roles of the carboxyl-terminal tail of the alpha(1B)-adrenergic receptor in its expression, function, and regulation were investigated by site-directed mutagenesis. The receptor construct truncated after residue 363 seemed not to be properly expressed. In contrast, the receptor truncated after residue 366 and all of the longer receptor constructs were properly expressed and exhibited agonist and antagonist binding and activation of phosphoinositide hydrolysis similar to the wild-type receptor. Agonist-induced sequestration of receptors within the plasma membrane, endocytosis into intracellular vesicles, and eventual down-regulation were all absent in the receptor truncated after residue 366. A series of sequential truncations and a deletion mutation identified a critical role for residues 403 to 425, which include the previously identified sites for G protein-coupled receptor kinase phosphorylation, in agonist-induced internalization of the receptor. Similar studies identified a critical role for residues 367 to 380 in agonist-induced downregulation. Individual point mutations converting either cysteine 367 or serine 369 to alanine selectively eliminated down-regulation, thus identifying two specific amino acid residues required for down-regulation. Importantly, several of the mutated receptors that failed to show rapid agonist-induced internalization nonetheless exhibited normal agonist-induced down-regulation. In addition to identifying specific regions and individual residues of the alpha(1B)-adrenergic receptor involved in internalization and down-regulation, these studies provide mutated receptors that internalize but do not down-regulate, that downregulate without internalization, and that are defective in both internalization and down-regulation, all of which should be useful tools for further studies of the specific cellular compartments and molecular mechanisms involved in receptor internalization and down-regulation.

A Juxtamembrane Mutation in the N Terminus of the Dopamine Transporter Induces Preference for an Inward-Facing Conformation

Site-Directed Mutations Near Transmembrane Domain 1 Alter Conformation and Function of Norepinephrine and Dopamine Transporters

Substrate-induced Conformational Dynamics of the Dopamine Transporter

Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation

Syntaxin 1a Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux

Structure of the human dopamine transporter and mechanisms of inhibition

Expression and regulation of the human dopamine transporter in a neuronal cell line (vol 59, pg 66, 1998)

Functional importance of two conserved residues in intracellular loop 1 and transmembrane region 2 of Family A GPCRs: Insights from ligand binding and signal transduction responses of D1 and D5 dopaminergic receptor mutants

Dopamine transporter endocytic trafficking: Neuronal mechanisms and potential impact on DA‐dependent behaviors

A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition

Dopamine reuptake and inhibitory mechanisms in human dopamine transporter

Structure of the human dopamine transporter in complex with cocaine

Dopamine Transporter Trafficking: Rapid Response on Demand.

Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity

Identification Of Distinct Carboxyl-Terminal Domains Mediating Internalization And Down-Regulation Of The Hamster Alpha(1b) Adrenergic Receptor

Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching

Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter

Rapid Delivery of the Dopamine Transporter to the Plasmalemmal Membrane Upon Amphetamine Stimulation

Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters

Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse

Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy